165 related articles for article (PubMed ID: 32486832)
1. The Changing Paradigm of Head and Neck Paragangliomas: What Every Otolaryngologist Needs to Know.
Cass ND; Schopper MA; Lubin JA; Fishbein L; Gubbels SP
Ann Otol Rhinol Laryngol; 2020 Nov; 129(11):1135-1143. PubMed ID: 32486832
[TBL] [Abstract][Full Text] [Related]
2. Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility.
Astuti D; Hart-Holden N; Latif F; Lalloo F; Black GC; Lim C; Moran A; Grossman AB; Hodgson SV; Freemont A; Ramsden R; Eng C; Evans DG; Maher ER
Clin Endocrinol (Oxf); 2003 Dec; 59(6):728-33. PubMed ID: 14974914
[TBL] [Abstract][Full Text] [Related]
3. Variant type is associated with disease characteristics in SDHB, SDHC and SDHD-linked phaeochromocytoma-paraganglioma.
Bayley JP; Bausch B; Rijken JA; van Hulsteijn LT; Jansen JC; Ascher D; Pires DEV; Hes FJ; Hensen EF; Corssmit EPM; Devilee P; Neumann HPH
J Med Genet; 2020 Feb; 57(2):96-103. PubMed ID: 31492822
[TBL] [Abstract][Full Text] [Related]
4. Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene.
Schiavi F; Boedeker CC; Bausch B; Peçzkowska M; Gomez CF; Strassburg T; Pawlu C; Buchta M; Salzmann M; Hoffmann MM; Berlis A; Brink I; Cybulla M; Muresan M; Walter MA; Forrer F; Välimäki M; Kawecki A; Szutkowski Z; Schipper J; Walz MK; Pigny P; Bauters C; Willet-Brozick JE; Baysal BE; Januszewicz A; Eng C; Opocher G; Neumann HP;
JAMA; 2005 Oct; 294(16):2057-63. PubMed ID: 16249420
[TBL] [Abstract][Full Text] [Related]
5. Mutations in SDHD are the major determinants of the clinical characteristics of Dutch head and neck paraganglioma patients.
Hensen EF; Siemers MD; Jansen JC; Corssmit EP; Romijn JA; Tops CM; van der Mey AG; Devilee P; Cornelisse CJ; Bayley JP; Vriends AH
Clin Endocrinol (Oxf); 2011 Nov; 75(5):650-5. PubMed ID: 21561462
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and spectrum of SDHx mutations in pheochromocytoma and paraganglioma in patients from Belgium: an update.
Persu A; Lannoy N; Maiter D; Mendola A; Montigny P; Oriot P; Vinck W; Garin P; Hamoir M; Vikkula M
Horm Metab Res; 2012 May; 44(5):349-53. PubMed ID: 22566194
[TBL] [Abstract][Full Text] [Related]
7. Clinical aspects of SDHx-related pheochromocytoma and paraganglioma.
Timmers HJ; Gimenez-Roqueplo AP; Mannelli M; Pacak K
Endocr Relat Cancer; 2009 Jun; 16(2):391-400. PubMed ID: 19190077
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of SDHB mutations in head and neck paraganglioma in Belgium.
Persu A; Hamoir M; Grégoire V; Garin P; Duvivier E; Reychler H; Chantrain G; Mortier G; Mourad M; Maiter D; Vikkula M
J Hypertens; 2008 Jul; 26(7):1395-401. PubMed ID: 18551016
[TBL] [Abstract][Full Text] [Related]
9. Genetics of hereditary head and neck paragangliomas.
Boedeker CC; Hensen EF; Neumann HP; Maier W; van Nederveen FH; Suárez C; Kunst HP; Rodrigo JP; Takes RP; Pellitteri PK; Rinaldo A; Ferlito A
Head Neck; 2014 Jun; 36(6):907-16. PubMed ID: 23913591
[TBL] [Abstract][Full Text] [Related]
10. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations.
Neumann HP; Pawlu C; Peczkowska M; Bausch B; McWhinney SR; Muresan M; Buchta M; Franke G; Klisch J; Bley TA; Hoegerle S; Boedeker CC; Opocher G; Schipper J; Januszewicz A; Eng C;
JAMA; 2004 Aug; 292(8):943-51. PubMed ID: 15328326
[TBL] [Abstract][Full Text] [Related]
11. The clinical phenotype of SDHC-associated hereditary paraganglioma syndrome (PGL3).
Else T; Marvin ML; Everett JN; Gruber SB; Arts HA; Stoffel EM; Auchus RJ; Raymond VM
J Clin Endocrinol Metab; 2014 Aug; 99(8):E1482-6. PubMed ID: 24758179
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Head and Neck Paragangliomas by Computed Tomography in Patients with Pheochromocytoma-Paraganglioma Syndromes.
Michałowska I; Lewczuk A; Ćwikła J; Prejbisz A; Swoboda-Rydz U; Furmanek MI; Szperl M; Januszewicz A; Pęczkowska M
Pol J Radiol; 2016; 81():510-518. PubMed ID: 27867439
[TBL] [Abstract][Full Text] [Related]
13. Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed Prevention.
Bausch B; Schiavi F; Ni Y; Welander J; Patocs A; Ngeow J; Wellner U; Malinoc A; Taschin E; Barbon G; Lanza V; Söderkvist P; Stenman A; Larsson C; Svahn F; Chen JL; Marquard J; Fraenkel M; Walter MA; Peczkowska M; Prejbisz A; Jarzab B; Hasse-Lazar K; Petersenn S; Moeller LC; Meyer A; Reisch N; Trupka A; Brase C; Galiano M; Preuss SF; Kwok P; Lendvai N; Berisha G; Makay Ö; Boedeker CC; Weryha G; Racz K; Januszewicz A; Walz MK; Gimm O; Opocher G; Eng C; Neumann HPH;
JAMA Oncol; 2017 Sep; 3(9):1204-1212. PubMed ID: 28384794
[TBL] [Abstract][Full Text] [Related]
14. Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma.
Bayley JP; van Minderhout I; Weiss MM; Jansen JC; Oomen PH; Menko FH; Pasini B; Ferrando B; Wong N; Alpert LC; Williams R; Blair E; Devilee P; Taschner PE
BMC Med Genet; 2006 Jan; 7():1. PubMed ID: 16405730
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive next generation sequencing-based genetic testing strategy to improve diagnosis of inherited pheochromocytoma and paraganglioma.
Rattenberry E; Vialard L; Yeung A; Bair H; McKay K; Jafri M; Canham N; Cole TR; Denes J; Hodgson SV; Irving R; Izatt L; Korbonits M; Kumar AV; Lalloo F; Morrison PJ; Woodward ER; Macdonald F; Wallis Y; Maher ER
J Clin Endocrinol Metab; 2013 Jul; 98(7):E1248-56. PubMed ID: 23666964
[TBL] [Abstract][Full Text] [Related]
16. Head and Neck Paragangliomas-A Genetic Overview.
Majewska A; Budny B; Ziemnicka K; Ruchała M; Wierzbicka M
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081307
[TBL] [Abstract][Full Text] [Related]
17. Head and neck paragangliomas: clinical and molecular genetic classification.
Offergeld C; Brase C; Yaremchuk S; Mader I; Rischke HC; Gläsker S; Schmid KW; Wiech T; Preuss SF; Suárez C; Kopeć T; Patocs A; Wohllk N; Malekpour M; Boedeker CC; Neumann HP
Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):19-28. PubMed ID: 22584701
[TBL] [Abstract][Full Text] [Related]
18. Reduced Risk of Corporal Tumors in Patients With Head and Neck Paragangliomas With p.Pro81Leu Mutations.
Miller KM; Sbeih F; Contrera K; Reddy CA; Marquard J; Eng C; Lorenz RR
Otolaryngol Head Neck Surg; 2023 Sep; 169(3):570-576. PubMed ID: 36939592
[TBL] [Abstract][Full Text] [Related]
19. Risk of metastatic pheochromocytoma and paraganglioma in
Lee H; Jeong S; Yu Y; Kang J; Sun H; Rhee JK; Kim YH
J Med Genet; 2020 Apr; 57(4):217-225. PubMed ID: 31649053
[TBL] [Abstract][Full Text] [Related]
20. Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes.
Benn DE; Gimenez-Roqueplo AP; Reilly JR; Bertherat J; Burgess J; Byth K; Croxson M; Dahia PL; Elston M; Gimm O; Henley D; Herman P; Murday V; Niccoli-Sire P; Pasieka JL; Rohmer V; Tucker K; Jeunemaitre X; Marsh DJ; Plouin PF; Robinson BG
J Clin Endocrinol Metab; 2006 Mar; 91(3):827-36. PubMed ID: 16317055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
